Drug Index

Mechanism :

Glucarpidase is a recombinant enzyme which rapidly hydrolyses the carboxyl-terminal glutamate residue from extracellular methotrexate into inactive metabolites (DAMPA and glutamate), resulting in a rapid reduction of methotrexate concentrations independent of renal function.

Indication :

  • Methotrexate toxicity

Contraindications :

No contraindications

Dosing :

Methotrexate toxicity:
IV 50 units/kg as a single dose; may require a second dose 24 hours later.
Note: Do not administer leucovorin calcium within 2 hours before or after glucarpidase.

Adverse Effect :

Antibody development, flushing, hypotension, headache, nausea, paraesthesia.

Interaction :

Leucovorin Calcium-Levoleucovorin: Glucarpidase may decrease serum concentrations of the active metabolite(s) of Leucovorin Calcium-Levoleucovorin.

Hepatic Dose :

No dosage adjustments are needed.
09/28/2020 07:36:36 Glucarpidase
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0